ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
1.760
-0.040 (-2.22%)
At close: Jul 10, 2026, 4:00 PM EDT
1.770
+0.010 (0.57%)
After-hours: Jul 10, 2026, 5:27 PM EDT
ProKidney Market Cap
ProKidney has a market cap or net worth of $531.62 million as of July 10, 2026. Its market cap has increased by 135.54% in one year.
Market Cap
531.62M
Enterprise Value
310.46M
1-Year Change
135.54%
Ranking
Category
Stock Price
$1.76
Market Cap Chart
Since June 30, 2021, ProKidney's market cap has increased from $258.80M to $531.62M, an increase of 105.42%. That is a compound annual growth rate of 15.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 531.60M | -21.12% |
| Dec 31, 2025 | 673.90M | 36.72% |
| Dec 31, 2024 | 492.90M | 17.61% |
| Dec 29, 2023 | 419.10M | -73.75% |
| Dec 30, 2022 | 1.60B | 405.76% |
| Dec 31, 2021 | 315.70M | 21.99% |
| Jun 30, 2021 | 258.80M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eikon Therapeutics | 572.79M |
| Contineum Therapeutics | 567.90M |
| XOMA Royalty | 554.56M |
| Assembly Biosciences | 542.99M |
| Arvinas | 533.59M |
| Kyverna Therapeutics | 515.85M |
| Shattuck Labs | 509.16M |
| Editas Medicine | 500.29M |